APA (7th ed.) Citation

Inciarte, A., Ugarte, A., Martínez-Rebollar, M., Torres, B., Fernández, E., Berrocal, L., . . . Group, f. t. D. S. (2023). Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate for Nonoccupational HIV-1 Postexposure Prophylaxis: A Prospective Open-Label Trial (DORAVIPEP). Open Forum Infectious Diseases, 10(8), 1. https://doi.org/10.1093/ofid/ofad374

Chicago Style (17th ed.) Citation

Inciarte, Alexy, et al. "Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate for Nonoccupational HIV-1 Postexposure Prophylaxis: A Prospective Open-Label Trial (DORAVIPEP)." Open Forum Infectious Diseases 10, no. 8 (2023): 1. https://doi.org/10.1093/ofid/ofad374.

MLA (9th ed.) Citation

Inciarte, Alexy, et al. "Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate for Nonoccupational HIV-1 Postexposure Prophylaxis: A Prospective Open-Label Trial (DORAVIPEP)." Open Forum Infectious Diseases, vol. 10, no. 8, 2023, p. 1, https://doi.org/10.1093/ofid/ofad374.